(Image: courtesy of the National Museum of Health and Medicine, Armed Forces Institute of Pathology, Washington, D.C., United States.) [CC BY 2.5 (https://creativecommons.org/licenses/by/2.5)], via Wikimedia Commons
Researchers at LSTM and Imperial College London have designed drugs which could help combat any potential new flu pandemic, by targeting the receptors of the cells by which the virus gains entry to the human body.
In a paper published today(link is external) in the Journal of Immunology the team, led by LSTM’s Professor Richard Pleass, show that by engineering a part of an antibody they can target the viral proteins that allow flu to mutate and become so deadly to humans.
Last year marked the centenary of the 1918 influenza pandemic that claimed nearly 100 million lives worldwide, thus becoming the deadliest disease outbreak in recorded history. Global annual influenza outbreaks account for 300,000-650,000 respiratory deaths, mostly in children and the elderly.
Professor Pleass explained: “Influenza vaccines have limited public health impact during pandemics, and current influenza vaccines are less efficacious than vaccines for many other infectious diseases. This is because influenza viruses that circulate in human and animal populations mutate two key viral surface proteins, haemagglutinin (HA) and neuraminidase (NA), thus allowing them to escape from protective antibodies produced through natural infection or vaccination”
Both HA and NA target a sugar called sialic acid, that is found in abundance on the receptors of cells lining the mammalian respiratory tract, which the virus uses to gain entry into the body. The sialic acid-binding contacts on HA and NA do not mutate readily, otherwise the virus would not be able to infect human cells.
The team has engineered antibody Fc fragments with enhanced sialic acid that target these conserved parts of both HA and NA, binding influenza viruses and thus blocking their interactions with human cells.
By targeting sialic acid, these engineered biologicals may also be useful in the control of other pathogens, such as group B streptococci, Streptococcus pneumoniae, Mycoplasma genitalium, and Newcastle Disease Virus.
“Better anti-influenza therapeutics are urgently needed.” Continued Professor Pleass: “The transfer of antibodies from people recovering from influenza during the 1918 and 2009 pandemics reduced mortality from influenza by 50% and 26% respectively. However, to be useful, these antibody medicines (also called FLU-IVIG) need to be manufactured in advance of future epidemics, which is obviously problematic as there may be modest or little neutralising activity against newly emerging strains. Therefore, combinations of existing medicines, including FLU-IVIG, with sialic acid blockers could increase their efficacy while future-proofing against the next pandemic.”
Professor Sara Marshall, Head of Clinical and Physiological Sciences at the Wellcome Trust, who provided funding for this work, said: “This is a fascinating project, and one which could have really far-reaching impact not only for influenza but as a platform technology to develop new medicines for many other diseases that are currently treated by antibodies.”
The technology described is available for licensing.
Learn more: LSTM and Imperial College Researchers design new anti-influenza drugs
The Latest on: Anti-influenza drugs
[google_news title=”” keyword=”anti-influenza drugs” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Anti-influenza drugs
- Children with severe form of epilepsy should receive flu vaccine due to high seizure risk after influenza infection, study findson November 16, 2022 at 6:21 am
Children with a severe form of epilepsy should be vaccinated against the flu due to the high risk of seizures being triggered by an influenza infection, according to a new study.
- Is the Flu Vaccine Mandate for Children With Epilepsyon November 15, 2022 at 10:32 pm
Can the flu vaccine cause seizures in children? Vaccinating children at the recommended age protects children against diseases that can cause seizures.
- Flu vaccination needed for children with severe form of epilepsy due to high seizure risk after influenza infectionon November 15, 2022 at 9:37 pm
Children with a severe form of epilepsy should be vaccinated against the flu due to the high risk of seizures being triggered by an influenza infection, according to a new study.
- Flu cases are rising in UAE: Doctors urge parents not to send infected kids to schoolon November 15, 2022 at 6:00 pm
Healthcare facilities in the UAE are witnessing a surge in paediatric patient footfall as flu cases are increasing with the onset of winter months. Doctors advise parents not to send their unwell ...
- Study: Children with severe form of epilepsy should receive flu vaccine due to high risk after influenza infectionon November 15, 2022 at 11:02 am
Children with a severe form of epilepsy should be vaccinated against the flu due to the high risk of seizures being triggered by an influenza infection, according to a new study.
- Flu cases are on the rise: Take these 8 steps to protect yourself and the communityon November 14, 2022 at 8:04 am
You can treat fever and cough with over-the-counter medicines such as anti-inflammatories (Ibuprofen ... Taking antiviral drugs early can help prevent serious flu complications. Most people who get ...
- Pharmacists adapting to meet demand for children's cold and flu medicationson November 13, 2022 at 5:52 pm
While pharmacy shelves may not be stocked with children's cold and flu medication as Canada deals with a national shortage, local pharmacists say parents have other options to help their children get ...
- Taking flu drugs before illness may create stronger viruson November 9, 2022 at 4:00 pm
It will have profound, harmful social effects.” Sugaya added: “If the trend of taking anti-flu drugs as a measure of prevention grows to a scale of 1,000 people, some will end up becoming ill ...
- Flu drug to be tested to see if it works against coronaviruson November 9, 2022 at 4:00 pm
The government has a stockpile of the anti-flu drug Avigan, also known by its generic name of Favipiravir. The drug was developed by Fujifilm Toyama Chemical Co. It was approved for use in 2014 on ...
- Anti-influenza Drugs Market 2022-2028 Leading Growth Drivers, Emerging Audience, Segments, Industry Sales, Profits & Analysison November 9, 2022 at 4:28 am
Nov 08, 2022 (The Expresswire) -- Number of Tables and Figures :115 | The global "Anti-influenza Drugs Market"size is projected to reach Multimillion USD by 2028, In comparison to 2021, at unexpected ...
via Bing News
